Sponsored by
Big news! The Musella Foundation teamed up with Kids Beating Cancer, the AYJ Fund, Tough2gether Foundation, DDRFA, and Springhood Ventures to help FLAG Therapeutics raise over $500,000 to push their promising drug, FLAG-003, toward clinical trials for kids with DIPG.
FLAG-003 has shown great results in preclinical testing. It crosses the blood-brain barrier and kills tumor cells through two powerful mechanisms, while sparing healthy cells. This could be a game-changer for DIPG and other brain tumors.
We're proud to be part of this initial funding, but we need to help them raise a lot more money to get this treatment to the kids who need it! If your organization wants to join in, contact me at musella@virtualtrials.org. Individuals can donate at virtualtrials.org/donate and mention it's for the FLAG project!